FUJISAWA USA INC (LYPHOMED INC) -- ARISTOSPAN 5 MG -- 6505-01-156-1663
===================== Product Identification =====================
Product ID:ARISTOSPAN 5 MG
MSDS Date:01/01/1994
FSC:6505
NIIN:01-156-1663
=== Responsible Party ===
Company Name:FUJISAWA USA INC (LYPHOMED INC)
Address:3 PARKWAY NORTH
City:DEERFIELD
State:IL
ZIP:60015-2548
Country:US
Info Phone Num:800-727-7003/708-317-8800
Emergency Phone Num:708-317-8202
Preparer's Name:CHRISTINA J BARRINGTON
CAGE:24832
=== Contractor Identification ===
Company Name:FUJISAWA USA INC (LYPHOMED INC)
Address:3 PARKWAY NORTH
City:DEERFIELD
State:IL
ZIP:60015-2548
Country:US
Phone:800-727-7003/708-317-8800
CAGE:24832
Company Name:FUJISAWA USA, INC
Address:3 PKY N
Box:City:DEERFIELD
State:IL
ZIP:60015-2548
Country:US
Phone:847-317-1256
CAGE:39832
============= Composition/Information on Ingredients =============
Ingred Name:BENZYL ALCOHOL
CAS:100-51-6
RTECS #:DN3150000
Ingred Name:POLYSORBATE 80 USP, POLYOXYETHYLENESORBITOL OLEATE, TWEEN
80
CAS:9005-65-6
RTECS #:WG2932500
Ingred Name:SORBITOL
CAS:50-70-4
RTECS #:LZ4290000
Ingred Name:TRIAMCINOLONE HEXACETONIDE
CAS:5611-51-8
RTECS #:TU3930000
Ingred Name:WATER
CAS:7732-18-5
RTECS #:ZC0110000
===================== Hazards Identification =====================
Routes of Entry: Inhalation:YES Skin:YES Ingestion:YES
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:IMMEDIATE EFFECTS: EYE, SKIN & MUCOUS
MEMBRANE IRRITATION MAY OCCUR. DELAYED EFFECTS: PRIMARY IRRITATION
OF SKIN/EYES, FLUID RETENTION, MUSCLE WEAKNESS, IMPAIRED WOUND
HEALING, HEADACHE, VERTIGO & CON VULSIONS HAVE BEEN REPORTED
W/PATIENT ADMINISTRATION.
Explanation of Carcinogenicity:NONE
Effects of Overexposure:IMMEDIATE EFFECTS: EYE, SKIN & MUCOUS MEMBRANE
IRRITATION MAY OCCUR. DELAYED EFFECTS: PRIMARY IRRITATION OF
SKIN/EYES, FLUID RETENTION, MUSCLE WEAKNESS, IMPAIRED WOUND
HEALING, HEADACHE, VERTIGO & CON VULSIONS HAVE BEEN REPORTED
W/PATIENT ADMINISTRATION.
Medical Cond Aggravated by Exposure:PRE-EXISTING SKIN CONDITIONS.
======================= First Aid Measures =======================
First Aid:INHALTION: MOVE TO FRESH AIR. GIVE CPR IF REQUIRED.
INGESTION: FLUSH MOUTH OUT W/WATER. SKIN: FLUSH AREA W/WATER FOR 15
MINS. EYES: FLUSH W/WATER FOR 15 MINS. OBTAIN MEDICAL ATTENTION IN
ALL CASES.
===================== Fire Fighting Measures =====================
Flash Point Method:CC
Flash Point: >200F
Extinguishing Media:WATER SPRAY, DRY CHEMICAL, CO2, FOAM.
Fire Fighting Procedures:WEAR SELF-CONTAINED BREATHING APPARATUS &
PROTECTIVE CLOTHING.
================== Accidental Release Measures ==================
Spill Release Procedures:WEAR RECOMMENDED PERSONAL PROTECTIVE
EQUIPMENT. USE ABSORBENT TOWELS/BOOMS TO CLEAN UP. WIPE SURFACES
CLEAN & WASH W/SOAP & WATER.
====================== Handling and Storage ======================
Handling and Storage Precautions:WHEN HANDLING PHARMACEUTICAL PRODUCTS,
AVOID CONTACT/INHALATION OF DUST, FUMES, MIST/VAPORS ASSOCIATED
W/PRODUCT.
============= Exposure Controls/Personal Protection =============
Respiratory Protection:NONE USUALLY REQUIRED W/SATISFACTORY
VENTILATION.
Ventilation:GENERAL ROOM USUALLY SATISFACTORY. LOCAL EXHAUST WHEN
NECESSARY.
Protective Gloves:DISPOSABLE LATEX
Eye Protection:SAFETY GLASSES/GOGGLES
Other Protective Equipment:DISPOSABLE GARMENTS
Work Hygienic Practices:REMOVE/LAUNDER CONTAMINATED CLOTHING BEFORE
REUSE.
Supplemental Safety and Health
PH: 4.5-6.5. THIS PRODUCT IS INTENDED FOR THERAPEUTIC USE ONLY WHEN
PRESCRIBED BY A PHYSICIAN.
================== Physical/Chemical Properties ==================
pH:SUPP
Solubility in Water:INSOLUBLE
Appearance and Odor:CLEAR STERILE SOLUTION
================= Stability and Reactivity Data =================
Stability Indicator/Materials to Avoid:YES
NONE
Stability Condition to Avoid:NONE
Hazardous Decomposition Products:SMOKE & FLUORINE FUMES
==================== Disposal Considerations ====================
Waste Disposal Methods:DISPOSE OF IAW/FEDERAL, STATE & LOCAL
REGULATIONS.
Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.